XML 50 R38.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREBASED COMPENSATION (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended
Aug. 31, 2023
Jan. 23, 2023
Sep. 30, 2023
Sep. 30, 2022
Unamortized stock-based compensation expense, restricted stock     $ 1,211,000  
Stock-based compensation expense     1,229,000  
Intrinsic value of outstanding and exercisable     0  
Common stock, total fair value     1,000 $ 2,000
2021 Equity Incentive Plan [Member]        
Description of restricted stock   The grant of the 1,250,000 shares of restricted common stock vest as follows: 33.3% vest each subsequent year from the date of grant    
Common stock shares issued   1,250,000    
Common stock, total fair value   $ 1,363,000    
Amended and Restated 2012 Equity Incentive Plan [Member]        
Description of restricted stock The grant of the 210,000 shares of restricted common stock vest as follows: 100% of 125,000 shares and 100% of 85,000 shares vesting on July 12, 2024 and September 27, 2024      
Common stock shares issued 210,000      
Common stock, total fair value $ 200,000      
Option [Member]        
Unamortized stock-based compensation expense, restricted stock     317,000  
Stock-based compensation expense, stock option     $ 316,000  
Common stock shares   540,000    
Common stock shares, exercise price   $ 1.09    
Aggregate fair value of the options   $ 429,000    
Fair value of the options discount rate   3.61%    
Fair value of the options, expexted term   3 years 6 months    
Fair value of the options, expected volatility   113.00%    
Description of option term   The options have a term of five years and fully vest in January 2026. 33.3% vest each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company